Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117268) titled 'Exploring the molecular mechanism of PIAS1 regulating ferroptosis by activating the TAL1/SLC7A11 axis and affecting the occurrence and development of non-small cell lung cancer based on SUMOylation modification' on Jan. 21.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Ningbo Medical Centre Lihuili Hospital
Condition:
Non-small cell lung cancer
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-02-01
Target Sample Size: Group of non-small cell lung cancer:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showpro...